ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0060003;copper ion export;10.0;0.9326813400603323;0.8815816818910864;9.56398573135455;101.53169440817886;9.083926447120524;0.0033981744392491903;0.8797934328124444;[ATP7A]
GO:0034198;cellular response to amino acid starvation;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;115.90251486529202;5.970411137910149;0.003879152867050031;0.6562464685024372;[BECN1]
GO:0071380;cellular response to prostaglandin E stimulus;8.0;1.0;0.875;9.628524252492122;704.3614414198233;6.943860283624253;0.023574343560179453;0.7301093378270707;[GNG2]
GO:0050796;regulation of insulin secretion;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;205.48125160941495;4.61801832846594;0.006877272570246766;0.6324062972578516;[ITPR2]
GO:0075732;viral penetration into host nucleus;9.0;0.8436909121759173;0.8180860812682478;9.454170865347344;158.53021989987354;9.083926447120524;0.005305863792113644;0.8607930461318132;[NUP153]
GO:0075733;intracellular transport of virus;6.0;0.7307253602413294;0.6884829927108091;8.98189708756707;41.40603827369937;7.138016298065211;0.0013858228380055914;0.6881587980249038;[NUP153, KPNB1]
GO:0048489;synaptic vesicle transport;7.0;0.7671156992804218;0.7344772148974115;9.292052015870908;108.01043080855717;5.459585514144159;0.003615011916085639;0.6301228223472235;[SYNJ1, SPG11]
GO:0000184;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;10.0;0.8933024483968273;0.861892236059334;9.57851383191746;717.2549128915896;4.989581884898423;0.0240058764469685;0.6704084614939124;[UPF2, SMG5, DCP2]
GO:0048488;synaptic vesicle endocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.00680757199006;6.599019797332524;0.0018410283465216937;0.6605944919115335;[SYNJ1]
GO:0000060;protein import into nucleus, translocation;9.0;1.0;0.896240625180289;9.628524252492122;93.4429707305496;6.444869117505266;0.0031274521371376313;0.7258315315665724;[TNPO2, KPNB1]
GO:0050435;amyloid-beta metabolic process;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;60.01596331221528;6.943860283624253;0.0020086802811995464;0.6782296504172152;[BECN1]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[WDR48, ATP7A]
GO:1904980;positive regulation of endosome organization;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;90.26399460910262;9.777073627680469;0.0030210546672455657;0.8509193652572005;[SYNJ1]
GO:0036124;histone H3-K9 trimethylation;12.0;1.0;0.9481203125901445;9.628524252492122;1326.076100831845;8.16763571524637;0.044382573703832605;0.8658135829017477;[ARID4A]
GO:2000010;positive regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;7.004484905440688;0.002466909593039506;0.7091290490632969;[TM9SF4]
GO:0036120;cellular response to platelet-derived growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.781341354126479;0.003262744749111514;0.6699184248047958;[ATP7A]
GO:1903779;regulation of cardiac conduction;7.0;0.6913464685778243;0.6965925995461126;8.763526815005518;28.828680454715183;5.788089581116195;9.648699906913433E-4;0.6469225356091749;[AHCYL1, ITPR2]
GO:0006610;ribosomal protein import into nucleus;10.0;1.0;0.9152410118609203;9.628524252492122;278.22868408041535;7.697632086000634;0.009312063666612497;0.8088982747154926;[TNPO2, KPNB1]
GO:0071361;cellular response to ethanol;6.0;1.0;0.8231203125901445;9.628524252492122;330.81194821622347;7.138016298065211;0.011071978195372667;0.6881587980249038;[ITPR2]
GO:0006605;protein targeting;9.0;0.7192862368539868;0.7558837436072825;9.182237149863703;93.4429707305496;4.015022244900292;0.0031274521371376313;0.6015690495021188;[PEX16, PEX19, PAN3, VPS41]
GO:0051893;regulation of focal adhesion assembly;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;59.47724087459839;5.769740442447999;0.0019906497260312257;0.6459841598043611;[CLASP1]
GO:0071481;cellular response to X-ray;7.0;1.0;0.8509193652572005;9.628524252492122;60.39874674087868;7.379178354882098;0.0020214916980741903;0.728290889492758;[NIPBL]
GO:0048251;elastic fiber assembly;6.0;1.0;0.8231203125901445;9.628524252492122;39.541318973862396;7.474488534686424;0.0013234123611784638;0.7053660038532718;[ATP7A]
GO:0048016;inositol phosphate-mediated signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;27.814661162170232;6.599019797332524;9.309316775279788E-4;0.6883935445785896;[ITPR2]
GO:0048015;phosphatidylinositol-mediated signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;5.649939242635378;8.845336528452411E-4;0.6398575208746181;[EXOC1]
GO:0072332;intrinsic apoptotic signaling pathway by p53 class mediator;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;80.0523555558605;5.734022359845919;0.002679280298012042;0.64415753539903;[EP300, KRCC1]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[NUP153, TNPO2, KPNB1]
GO:0006607;NLS-bearing protein import into nucleus;10.0;1.0;0.9152410118609203;9.628524252492122;278.22868408041535;6.481236761676141;0.009312063666612497;0.7466917612613706;[TNPO2, KPNB1]
GO:0071364;cellular response to epidermal growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.088194173566533;0.003262744749111514;0.63447084575632;[BECN1]
GO:0015679;plasma membrane copper ion transport;10.0;0.9326813400603323;0.8815816818910864;9.56398573135455;101.53169440817886;9.083926447120524;0.0033981744392491903;0.8797934328124444;[ATP7A]
GO:0015677;copper ion import;9.0;0.8933024483968273;0.8428918493787028;9.427853557029971;21.372061049954535;7.697632086000634;7.153036497357847E-4;0.7898978880348613;[ATP7A]
GO:0043923;positive regulation by host of viral transcription;11.0;1.0;0.9324289523296623;9.628524252492122;272.30213926078306;6.943860283624253;0.009113707545043459;0.7875382901567328;[EP300, CHD1]
GO:0060260;regulation of transcription initiation from RNA polymerase II promoter;11.0;0.7980440201809971;0.8314509624201607;9.474373572664863;533.6092389555857;6.409777797693995;0.01785942101070673;0.7602252869888839;[DR1, TAF7]
GO:0035261;external genitalia morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;35.796394035251524;9.083926447120524;0.0011980730936967897;0.7547934328124444;[NIPBL]
GO:1900034;regulation of cellular response to heat;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;29.43425144606613;5.970411137910149;9.851379067933503E-4;0.6284474158353811;[EP300]
GO:0043928;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;11.0;0.9326813400603323;0.8987696223598284;9.60383163990175;718.8643508040237;6.280566066213989;0.024059742885497587;0.7536173930320365;[CNOT6, CNOT8, DCP2]
GO:1904754;positive regulation of vascular associated smooth muscle cell migration;9.0;1.0;0.896240625180289;9.628524252492122;244.58802208207217;7.212124270218933;0.008186140984158152;0.7650689957573628;[ATP7A]
GO:0071280;cellular response to copper ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.518977089658987;0.0026274528238337297;0.6565011041187423;[BECN1, ATP7A]
GO:0071281;cellular response to iron ion;6.0;0.8933024483968273;0.7697715367885581;9.461470167828956;78.90930355153202;7.697632086000634;0.002641023376107184;0.7167775754447168;[ATP7A]
GO:0000398;mRNA splicing, via spliceosome;11.0;0.8259837884571596;0.845420846558242;9.4949928598676;356.66873027722005;4.19357731889877;0.011937381421361158;0.6468886914394342;[EFTUD2, PCF11, CPSF2, DDX42, DDX41, SLU7, SMNDC1, SRRM1]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[EP300]
GO:0000045;autophagosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;62.10424204613046;5.769740442447999;0.0020785730910948433;0.618185107137305;[BECN1]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[SETX, KARS, PTPRA]
GO:0051542;elastin biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;392.9538634223855;9.777073627680469;0.013151812173230124;0.8509193652572005;[ATP7A]
GO:0071275;cellular response to aluminum ion;6.0;1.0;0.8231203125901445;9.628524252492122;77.8106912628645;9.777073627680469;0.002604253811492351;0.8231203125901445;[BECN1]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[PDCD6IP, SPAST]
GO:0071276;cellular response to cadmium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.139487467954083;0.0026274528238337297;0.6370939872166814;[ATP7A]
GO:0036109;alpha-linolenic acid metabolic process;9.0;1.0;0.896240625180289;9.628524252492122;214.3732045654151;7.212124270218933;0.0071748782334459795;0.7650689957573628;[ELOVL5, FADS1]
GO:0071279;cellular response to cobalt ion;6.0;1.0;0.8231203125901445;9.628524252492122;77.8106912628645;8.390779266560578;0.002604253811492351;0.7522251544931926;[ATP7A]
GO:0048260;positive regulation of receptor-mediated endocytosis;8.0;0.811012628672052;0.780506314336026;9.34084218004034;175.1727623766804;5.8650506222523235;0.005862874711496551;0.6749389615747303;[RAB21, SYNJ1]
GO:2001224;positive regulation of neuron migration;8.0;0.8933024483968273;0.8216512241984136;9.59462270081644;536.247192550588;7.138016298065211;0.017947710943527356;0.7400384854347593;[NIPBL]
GO:2000378;negative regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;113.12708673636307;5.905872616772578;0.003786261785297929;0.6251469128630576;[BECN1, AATF]
GO:0033197;response to vitamin E;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;57.68202331572161;7.292166977892469;0.00193056540992653;0.7238411236270654;[BECN1]
GO:0000289;nuclear-transcribed mRNA poly(A) tail shortening;10.0;0.9326813400603323;0.8815816818910864;9.603206444507832;717.2549128915896;6.686031174322154;0.0240058764469685;0.7571649570480019;[CNOT6, PAN3, CNOT1, CNOT10, CNOT8]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[MTPN, CASP2]
GO:0000296;spermine transport;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;78.81600447418118;9.777073627680469;0.00263790073995197;0.8509193652572005;[TAF7]
GO:0005977;glycogen metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;182.57737249811964;5.885253329569843;0.006110700348544658;0.6518914942236709;[PPP1CB]
GO:0000290;deadenylation-dependent decapping of nuclear-transcribed mRNA;10.0;1.0;0.9152410118609203;9.628524252492122;717.2549128915896;7.474488534686424;0.0240058764469685;0.7974867031240476;[PAN3, DCP2]
GO:2000144;positive regulation of DNA-templated transcription, initiation;11.0;0.8933024483968273;0.8790801765280758;9.604426700913061;1600.8530134724567;6.444869117505266;0.05357910968674749;0.7620198587159455;[SETX]
GO:0036336;dendritic cell migration;6.0;0.8436909121759173;0.7449657686781032;9.405380701177911;29.137022145890857;6.7325511899570465;9.751899096054872E-4;0.6674232935401965;[DOCK8]
GO:0016569;covalent chromatin modification;5.0;0.5374962537808747;0.5589891387513577;7.383097573338024;32.63830298611046;3.836902374960038;0.001092374628379458;0.4864603777505843;[DR1, ARID4A, EP300, CHD1, RLF]
GO:0048557;embryonic digestive tract morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;31.256231937100466;6.832634648514029;0.0010461179541522844;0.639662265535933;[NIPBL]
GO:0061418;regulation of transcription from RNA polymerase II promoter in response to hypoxia;12.0;0.8933024483968273;0.8947715367885583;9.557065288509976;532.6985892857467;6.311337724880743;0.017828942385788714;0.770882417347765;[EP300]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[PEX16, VPS18, AHCYL1, RABGAP1, PEX19, NUP153, ARCN1, RAB21, PAN3, VPS41, RAB18, TMED2, TNPO2, SEC24C, SLU7, KPNB1]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[TMEM30A, PSMB1, VPS41, RAB18, VAMP4, DOCK2, SNAP29, KPNB1, EXOC1]
GO:0032922;circadian regulation of gene expression;6.0;1.0;0.8231203125901445;9.628524252492122;31.18462308171688;5.769740442447999;0.0010437212702063816;0.618185107137305;[PPP1CB]
GO:0032801;receptor catabolic process;6.0;0.8436909121759173;0.7449657686781032;9.34084218004034;102.12013474586499;6.518977089658987;0.003417869007789623;0.6565011041187423;[BECN1]
GO:0006878;cellular copper ion homeostasis;10.0;0.8653626801206646;0.8479223519212526;9.523163736834295;186.04478652569694;7.138016298065211;0.006226751575577643;0.7802794972956796;[ATP7A]
GO:0006636;unsaturated fatty acid biosynthetic process;9.0;0.7508913569872202;0.7716863036738992;9.34084218004034;458.36729553176707;6.343086423195323;0.01534114087766428;0.7206263598461826;[ELOVL5, FADS1]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[BECN1, DDX41, SERINC3, EXOC1]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[ATP7A]
GO:0016575;histone deacetylation;9.0;0.7866048967936545;0.7895430735771163;9.396722638434797;357.60632662761185;5.682729065458369;0.011968761927426838;0.6868556538617572;[ARID4A]
GO:0051601;exocyst localization;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;40.77205030767364;7.57984905034425;0.001364603831334836;0.710754145523778;[EXOC1]
GO:0014037;Schwann cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;23.145667324477426;7.8311634786251565;7.746646556020492E-4;0.6907270763441554;[NAB1]
GO:0080182;histone H3-K4 trimethylation;12.0;1.0;0.9481203125901445;9.628524252492122;1138.7372665109895;7.069023426578259;0.03811251151311841;0.8096304993685645;[ARID4A]
GO:0035195;gene silencing by miRNA;10.0;1.0;0.9152410118609203;9.628524252492122;181.23087468718478;7.379178354882098;0.006065634278582023;0.7926125360964777;[CNOT6, CNOT1, CNOT8]
GO:1901673;regulation of mitotic spindle assembly;10.0;1.0;0.9152410118609203;9.628524252492122;218.77880646863287;6.832634648514029;0.0073223297643623805;0.7646622655359331;[STAG2, TPR]
GO:1901796;regulation of signal transduction by p53 class mediator;7.0;0.7192862368539868;0.710562483684194;9.117698628726131;45.070113835906206;4.948759890378168;0.001508456149618737;0.6039991761920099;[EP300, TAF7, SENP2, RFFL]
GO:0006893;Golgi to plasma membrane transport;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;32.11060110714162;5.845247994956144;0.0010747129213912287;0.6498456195510879;[SYS1, EXOC1]
GO:1901797;negative regulation of signal transduction by p53 class mediator;8.0;0.8259837884571596;0.7879918942285797;9.466005322994347;239.487551390376;6.409777797693995;0.008015432820232688;0.7027963346592216;[SENP2, RFFL]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[SYNJ1, FNBP1, WIPF2, DOCK2, TM9SF4]
GO:0048208;COPII vesicle coating;6.0;1.0;0.8231203125901445;9.628524252492122;62.43707956725794;5.6339389012889365;0.0020897128633926582;0.6112402100070131;[TRAPPC6B, TMED2, SEC24C]
GO:0006406;mRNA export from nucleus;9.0;0.8933024483968273;0.8428918493787028;9.523163736834295;121.36021434248079;5.132682728539097;0.004061817156940898;0.658726258611935;[UPF2, TPR, CPSF2, NUP153, SLU7, SMG5, SRRM1]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[DCTN5, SPAST, TRAPPC6B, GOLGB1, DCTN4, TMED2, SEC24C, ARCN1]
GO:0070233;negative regulation of T cell apoptotic process;10.0;0.8259837884571596;0.8282329060895002;9.370695143190021;155.57980234840144;6.7325511899570465;0.005207115971869279;0.7595439928109722;[DOCK8]
GO:0071320;cellular response to cAMP;7.0;1.0;0.8509193652572005;9.628524252492122;327.37290077043656;5.825829909099042;0.01095687637230394;0.6488525777373224;[ITPR2]
GO:0072657;protein localization to membrane;5.0;0.5756379274792419;0.5780599756005412;7.585450354983161;29.829169826127035;3.7017275965917853;9.983554695705216E-4;0.4795475332985618;[PEX16, SYS1, PEX19, TMED2, TM9SF4]
GO:2000045;regulation of G1/S transition of mitotic cell cycle;8.0;0.7436939687323844;0.7468469843661922;9.040737587590003;58.63952701093024;4.821246570079209;0.0019626121969077833;0.6215587738047448;[ANKRD17, CNOT6, CNOT1, CASP2, EP300, CNOT10, SENP2, CNOT8]
GO:0016320;endoplasmic reticulum membrane fusion;6.0;1.0;0.8231203125901445;9.628524252492122;42.182229872120345;9.083926447120524;0.0014118012722776551;0.7876727335416686;[VCPIP1]
GO:0030851;granulocyte differentiation;6.0;0.8653626801206646;0.7558016526504768;9.310070521373587;47.07409398820286;7.069023426578259;0.0015755275618510598;0.6846304993685643;[SP3]
GO:0016202;regulation of striated muscle tissue development;6.0;0.6108066114563391;0.628523618318314;8.273978589686811;41.666489171895165;4.964889272308052;0.001394539895177614;0.5770249808669412;[MTPN]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[VCPIP1, UBE2I, HERC1, KCTD10, RNF38, ZFP91, FBXL3, RFFL, C18orf25]
GO:0035067;negative regulation of histone acetylation;11.0;0.811012628672052;0.8379352666656883;9.498471124243924;1304.334881216342;6.943860283624253;0.04365491464912905;0.7875382901567328;[TAF7]
GO:1902894;negative regulation of pri-miRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;2093.976898733065;7.292166977892469;0.07008352234373612;0.8210420709600095;[YY1]
GO:2001271;negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis;13.0;1.0;0.9625549647676366;9.628524252492122;947.5852765280836;8.67846133901236;0.03171482643401269;0.9063718812344532;[RFFL]
GO:1904959;regulation of cytochrome-c oxidase activity;9.0;0.8933024483968273;0.8428918493787028;9.537552474286395;156.28382840288265;9.083926447120524;0.005230679090330452;0.8607930461318132;[ATP7A]
GO:0006986;response to unfolded protein;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;23.958124258549983;5.75172193694532;8.018568580216882E-4;0.5843843391987277;[HERPUD2]
GO:1904837;beta-catenin-TCF complex assembly;5.0;1.0;0.7902410118609202;9.628524252492122;40.42272244673708;6.409777797693995;0.0013529121422039536;0.618037346520142;[TLE4, EP300]
GO:0071230;cellular response to amino acid stimulus;6.0;0.7140352122741334;0.6801379187272112;8.962045319014338;283.89643900763554;5.6339389012889365;0.009501758323378283;0.6112402100070131;[ATP7A]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[CNOT6, CNOT1, CASP2, EP300, CNOT10, CNOT8]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CLASP1, PAFAH1B1]
GO:0071236;cellular response to antibiotic;4.0;0.6369964171292115;0.5684982085646058;7.703233390639544;41.40086873190647;5.085725745451326;0.0013856498180940687;0.5100842511328143;[SETX, BECN1, ITPR2, ATP7A]
GO:0050775;positive regulation of dendrite morphogenesis;11.0;0.9326813400603323;0.8987696223598284;9.600353375525426;973.0251821613764;6.250713103064308;0.03256627718113036;0.7520907111082569;[RAB21, PAFAH1B1]
GO:0042921;glucocorticoid receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;54.70458253798286;7.8311634786251565;0.0018309131466183446;0.7967266896635242;[NCOA6]
GO:0014015;positive regulation of gliogenesis;8.0;0.7307253602413294;0.7403626801206646;9.25696069605964;336.548297872056;5.75172193694532;0.011263968655973863;0.6691433273378073;[SYNJ1]
GO:0034088;maintenance of mitotic sister chromatid cohesion;4.0;0.8653626801206646;0.6826813400603323;9.158520623246385;27.51648075733887;8.390779266560578;9.20951847723215E-4;0.6791048419030481;[NIPBL]
GO:0034087;establishment of mitotic sister chromatid cohesion;4.0;1.0;0.75;9.628524252492122;27.51648075733887;9.083926447120524;9.20951847723215E-4;0.714552420951524;[NIPBL]
GO:1902425;positive regulation of attachment of mitotic spindle microtubules to kinetochore;10.0;0.9326813400603323;0.8815816818910864;9.598671289342441;865.6588713797479;9.083926447120524;0.028972823382675636;0.8797934328124444;[BECN1]
GO:0006990;positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response;13.0;1.0;0.9625549647676366;9.628524252492122;1470.606783206999;8.67846133901236;0.04921988557375968;0.9063718812344532;[EP300]
GO:0006995;cellular response to nitrogen starvation;7.0;0.8259837884571596;0.7639112594857803;9.405380701177911;176.14763520758262;7.212124270218933;0.005895502827818261;0.7197477358342742;[BECN1]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[TLE4, DVL3]
GO:0030953;astral microtubule organization;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;97.68103242922432;7.8311634786251565;0.0032692962481843716;0.7514054297404357;[KPNB1, CLASP1]
GO:0090091;positive regulation of extracellular matrix disassembly;7.0;1.0;0.8509193652572005;9.628524252492122;86.12905664991239;7.8311634786251565;0.0028826620149540304;0.7514054297404357;[CLASP1]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[CLASP1, PAFAH1B1]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[ANKRD17, SERINC3]
GO:0048596;embryonic camera-type eye morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;49.04309196241917;7.292166977892469;0.0016414281520649497;0.7238411236270654;[SP3]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[YY1]
GO:0071108;protein K48-linked deubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;204.99431233642397;6.375876246018314;0.006860975150996652;0.7413036195908642;[VCPIP1]
GO:0042415;norepinephrine metabolic process;7.0;0.8933024483968273;0.7975705894556142;9.485423408851448;81.97012092834949;7.292166977892469;0.0027434661791524667;0.7238411236270654;[ATP7A]
GO:0042417;dopamine metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.503361109538115;117.20956159213898;6.409777797693995;0.003922898544731914;0.6787156999164222;[ATP7A]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[BECN1]
GO:0002082;regulation of oxidative phosphorylation;10.0;0.7671156992804218;0.7987988615011312;9.466005322994347;169.9484663077979;6.641579411751319;0.005688022223632264;0.7548916918429109;[ATP7A]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[PEX16, VPS18, AHCYL1, SYS1, PDCD6IP, RABGAP1, PEX19, VPS33B, NUP153, SENP2, ARCN1, RAB21, PAN3, VPS41, RAB18, TMED2, TNPO2, SEC24C, SNAP29, SLU7, KPNB1, PAFAH1B1, EXOC1]
GO:0036092;phosphatidylinositol-3-phosphate biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;663.4179201744114;5.8650506222523235;0.02220400075087234;0.6961795867550195;[SYNJ1]
GO:0042771;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;8.0;1.0;0.875;9.628524252492122;164.97679920792456;6.409777797693995;0.005521625000009403;0.7027963346592216;[EP300]
GO:0006564;L-serine biosynthetic process;10.0;1.0;0.9152410118609203;9.628524252492122;563.0954422464521;7.8311634786251565;0.01884629769899192;0.8157270763441555;[SERINC3]
GO:0006568;tryptophan metabolic process;8.0;0.7671156992804218;0.7585578496402109;9.310070521373587;377.5827903470136;7.292166977892469;0.012637356190465077;0.747921758369865;[ATP7A]
GO:0042414;epinephrine metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;81.97012092834949;8.67846133901236;0.0027434661791524667;0.7947362817240173;[ATP7A]
GO:0045921;positive regulation of exocytosis;8.0;0.6913464685778243;0.7206732342889122;8.870838550794605;171.96353606350112;5.407625775213448;0.00575546479491061;0.6515462336247315;[PDCD6IP, CLASP1]
GO:0051247;positive regulation of protein metabolic process;6.0;0.4431761932209717;0.5447084092006304;6.724359172463622;129.0405071032027;2.3912225495552604;0.00431886964382753;0.4454075449776211;[MTPN, NIPBL, UBE2I, WDR48, KARS, ALS2, PPP1R7, DVL3, ZFP91, CIB1, SENP2]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[MTPN, CIB1, PAFAH1B1]
GO:0051123;RNA polymerase II transcriptional preinitiation complex assembly;8.0;1.0;0.875;9.628524252492122;67.28910983117808;6.7325511899570465;0.002252105949782328;0.719302980950052;[TAF7]
GO:0097368;establishment of Sertoli cell barrier;6.0;1.0;0.8231203125901445;9.628524252492122;53.96940310801916;8.16763571524637;0.0018063073527159906;0.7408135829017477;[ARID4A]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[DCTN5, DCTN4, SEC24C]
GO:0051127;positive regulation of actin nucleation;12.0;0.9326813400603323;0.9144609826203107;9.59953671561887;617.551681028286;6.943860283624253;0.02066889900358683;0.8032296504172152;[WIPF2]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[RFFL]
GO:0090503;RNA phosphodiester bond hydrolysis, exonucleolytic;8.0;0.8436909121759173;0.7968454560879586;9.466005322994347;231.13671471601307;6.166155715036245;0.007735937832006836;0.6903374900225189;[CNOT6, PAN3, CNOT1, CNOT8, DCP2]
GO:1905672;negative regulation of lysosome organization;8.0;1.0;0.875;9.628524252492122;91.47886526238142;9.777073627680469;0.0030617152946982025;0.875;[BECN1]
GO:0021707;cerebellar granule cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;49.9926366230673;7.8311634786251565;0.0016732085573221292;0.7236063770733796;[MTPN]
GO:0042428;serotonin metabolic process;5.0;0.8653626801206646;0.7229223519212526;9.533214072687796;239.02389494281553;7.474488534686424;0.00799991465619655;0.6724867031240476;[ATP7A]
GO:0043518;negative regulation of DNA damage response, signal transduction by p53 class mediator;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;408.0520127891259;7.138016298065211;0.013657133645082668;0.7612791106150483;[SENP2]
GO:0045815;positive regulation of gene expression, epigenetic;7.0;0.7763722522362496;0.7391054913753253;9.081980546124052;79.85422672196849;5.8650506222523235;0.0026726491042460506;0.6508583268319309;[EP300]
GO:0021702;cerebellar Purkinje cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;49.9926366230673;7.57984905034425;0.0016732085573221292;0.710754145523778;[HERC1, ATP7A]
GO:0040001;establishment of mitotic spindle localization;7.0;0.8933024483968273;0.7975705894556142;9.577230958104572;138.61878563688504;6.481236761676141;0.0046394460064588475;0.6823701146576509;[KPNB1, CLASP1, PAFAH1B1]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[PDCD6IP, SPAST, KCTD10]
GO:0009725;response to hormone;4.0;0.5257808277979137;0.5128904138989568;7.033269545535256;21.85620986101781;3.280298637494607;7.315076747364311E-4;0.41775462487096104;[YY1, GNG2, NCOA6]
GO:0051013;microtubule severing;6.0;1.0;0.8231203125901445;9.628524252492122;33.1981629444775;7.8311634786251565;0.0011111126373447525;0.7236063770733796;[SPAST]
GO:0051497;negative regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;338.83785420150645;6.781341354126479;0.01134059804585365;0.7792270645443136;[CLASP1]
GO:0016240;autophagosome membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;8.390779266560578;7.158639954716971E-4;0.7193458537639684;[SNAP29]
GO:0031629;synaptic vesicle fusion to presynaptic active zone membrane;8.0;1.0;0.875;9.628524252492122;97.90557556088102;7.212124270218933;0.0032768115047252227;0.7438283705770736;[SNAP29]
GO:0016241;regulation of macroautophagy;7.0;0.6729672293956388;0.6874029799550199;8.606873004960141;45.30384692040349;4.7081694254602375;0.0015162789856107417;0.5916953686275062;[BECN1, CALCOCO2, EXOC1]
GO:0140066;peptidyl-lysine crotonylation;8.0;1.0;0.875;9.628524252492122;153.63965937405905;9.777073627680469;0.005142181132533355;0.875;[EP300]
GO:0140067;peptidyl-lysine butyrylation;8.0;1.0;0.875;9.628524252492122;153.63965937405905;9.777073627680469;0.005142181132533355;0.875;[EP300]
GO:0022900;electron transport chain;4.0;0.7140352122741334;0.6070176061370667;8.475844742553736;29.758801740447502;4.623782033182691;9.96000313069993E-4;0.48646042820481683;[TXNRD1, COX5B]
GO:0042795;snRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1410.6487555617684;5.528578385631111;0.047213144347195396;0.730852068336507;[INTS3, INTS4]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[DR1, NCOA6, NFYC, ARID4A, DDX41, AATF, SENP2, RLF, FLI1, YY1, SETX, NIPBL, NFIC, SP3, DPF2, EP300, TAF7, ZNF564, IER2]
GO:0040018;positive regulation of multicellular organism growth;6.0;1.0;0.8231203125901445;9.628524252492122;145.45792876686207;6.280566066213989;0.004868345972189967;0.6443087532925187;[NIPBL]
GO:0043403;skeletal muscle tissue regeneration;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;44.68137006025916;7.004484905440688;0.0014954452452945145;0.6484506956670166;[MTPN]
GO:0006302;double-strand break repair;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;183.0506323445446;4.689477292448085;0.006126539929698291;0.6148200868187911;[YY1, SETX, NIPBL, WDR48, CIB1]
GO:0006665;sphingolipid metabolic process;6.0;0.6073376606709605;0.6267891429256247;8.442900586834382;65.68188383398223;4.786641040901733;0.0021983135420656713;0.5679093580234316;[ELOVL5, SERINC3]
GO:0006417;regulation of translation;7.0;0.5221699919663294;0.6120043612403652;8.01908634005802;212.8215771898108;3.9901762463137618;0.007122946661558481;0.554977164055858;[MTPN, ATXN2, CNOT6, CNOT1, TPR, CNOT10, EIF4E2, CNOT8]
GO:0051146;striated muscle cell differentiation;5.0;0.7436939687323844;0.6620879962271125;8.781226392104918;21.75937296335754;5.825829909099042;7.282666309192915E-4;0.5881742243410422;[MTPN]
GO:0006658;phosphatidylserine metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.466005322994347;192.1199672242072;6.375876246018314;0.00643008240624912;0.6769819729871445;[SERINC3]
GO:0030520;intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;54.01143535742291;6.7325511899570465;0.0018077141342769656;0.719302980950052;[NCOA6, TAF7]
GO:0051028;mRNA transport;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;42.48893056556077;4.77312732173501;0.0014220662684744023;0.6190979532066485;[UPF2, TPR, CPSF2, NUP153, SENP2, SLU7, SMG5, SRRM1]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[YY1, BECN1, VCPIP1, WDR48, PSMB1]
GO:1903036;positive regulation of response to wounding;6.0;0.6634067003016617;0.6548236627409754;8.340669964185484;43.19848215908081;5.769740442447999;0.0014458143217545424;0.618185107137305;[ATP7A]
GO:1901098;positive regulation of autophagosome maturation;9.0;1.0;0.896240625180289;9.628524252492122;490.39656958283985;7.8311634786251565;0.01641313185567848;0.7967266896635242;[CALCOCO2]
GO:0006310;DNA recombination;7.0;0.612588685250814;0.6572137078826075;8.529911963824013;149.0421272461911;4.488806596985934;0.0049883058697239;0.5804771433779154;[YY1, SETX, NIPBL, WDR48, NCOA6]
GO:0043651;linoleic acid metabolic process;9.0;1.0;0.896240625180289;9.628524252492122;192.24999652429597;6.943860283624253;0.006434434369904319;0.7513499630073597;[ELOVL5, FADS1]
GO:0097352;autophagosome maturation;5.0;1.0;0.7902410118609202;9.628524252492122;38.04764185170599;6.599019797332524;0.0012734203321220245;0.6277151911823093;[SNAP29]
GO:0030516;regulation of axon extension;10.0;0.7866048967936545;0.8085434602577476;9.474373572664863;209.02857457674645;5.244474134527214;0.0069959982775799475;0.6834436629936306;[RAB21, PAFAH1B1]
GO:0006309;apoptotic DNA fragmentation;9.0;1.0;0.896240625180289;9.628524252492122;682.1166149099336;7.004484905440688;0.022829829235937554;0.7544503089863854;[KPNB1]
GO:0010804;negative regulation of tumor necrosis factor-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;306.2706419112467;6.7325511899570465;0.010250602759086841;0.719302980950052;[RFFL]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[CLK1, ZMYM2, CLK4]
GO:0061014;positive regulation of mRNA catabolic process;9.0;0.7586651285174919;0.775573189439035;9.398000593880289;689.1938106655065;6.063501560976162;0.023066696608813914;0.706328376990269;[CNOT1, CNOT8]
GO:0022604;regulation of cell morphogenesis;5.0;0.5326392268888578;0.5565606253053492;7.3549266963713285;31.055921926933518;3.6012063575747084;0.001039413758379302;0.47440687246051283;[RAB21, ZMYM2, WIPF2, DVL3, CIB1, PAFAH1B1]
GO:0015074;DNA integration;7.0;0.8933024483968273;0.7975705894556142;9.567899630675686;149.0421272461911;6.943860283624253;0.0049883058697239;0.7060287030842711;[RLF]
GO:1902237;positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;829.3805359816347;7.292166977892469;0.027758620145282933;0.7881627702307852;[SERINC3]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[NFIC, NFYC, INTS3, INTS4, ARID4A, EP300, LCOR, TAF7, IER2, FLI1]
GO:0008543;fibroblast growth factor receptor signaling pathway;8.0;0.7090535922965819;0.729526796148291;8.567652291806858;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[SETX]
GO:0006369;termination of RNA polymerase II transcription;9.0;0.8933024483968273;0.8428918493787028;9.5544162803384;477.15162764714074;6.139487467954083;0.015969835568764485;0.7102142998068259;[SETX, PCF11, CPSF2]
GO:0098780;response to mitochondrial depolarisation;4.0;0.811012628672052;0.655506314336026;9.223059144383958;28.997869804256865;6.832634648514029;9.705326059599744E-4;0.5994212536750128;[BECN1]
GO:0097692;histone H3-K4 monomethylation;12.0;1.0;0.9481203125901445;9.628524252492122;768.6933950049562;9.777073627680469;0.025727476151674485;0.9481203125901445;[RLF]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[TAF7]
GO:0032526;response to retinoic acid;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;43.78950961223322;5.123113277522946;0.0014655954787213788;0.5522372631225753;[SETX, SYNJ1]
GO:0030220;platelet formation;5.0;1.0;0.7902410118609202;9.628524252492122;33.79744107268718;6.832634648514029;0.0011311699369806302;0.639662265535933;[EP300, CIB1]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[TLE4, GNG2, DVL3, SENP2]
GO:0010613;positive regulation of cardiac muscle hypertrophy;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;95.57844489853944;6.444869117505266;0.003198924535738274;0.7045909063862833;[BECN1, MTPN]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[RAB21, SETX, TMEM30A, DVL3, PAFAH1B1]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[ITPR2]
GO:0030224;monocyte differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;69.52661413212034;7.004484905440688;0.0023269932051117304;0.6813299963962409;[SP3]
GO:0017148;negative regulation of translation;8.0;0.6493065804076676;0.6996532902038338;9.081980546124052;1114.6737408694362;4.99795013456894;0.03730712696566269;0.6305954023103058;[CNOT1, TPR, CNOT10, EIF4E2, CNOT8]
GO:0061485;memory T cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;53.24038617789342;9.777073627680469;0.0017819078121373234;0.8509193652572005;[DOCK8]
GO:1903690;negative regulation of wound healing, spreading of epidermal cells;8.0;1.0;0.875;9.628524252492122;396.72827980217687;8.390779266560578;0.013278138492707536;0.8041048419030481;[CLASP1]
GO:0044804;autophagy of nucleus;5.0;0.8933024483968273;0.736892236059334;9.405380701177911;39.83166466328102;6.7325511899570465;0.0013331299701091492;0.6345439928109722;[BECN1]
GO:0060271;cilium assembly;6.0;0.8653626801206646;0.7558016526504768;9.405380701177911;137.68250629835126;4.347727998726029;0.00460810957959482;0.5454633246350222;[SNAP29]
GO:0007223;Wnt signaling pathway, calcium modulating pathway;9.0;1.0;0.896240625180289;9.628524252492122;33.206889128170424;6.250713103064308;0.001111404694859899;0.7159023839588838;[GNG2]
GO:0006376;mRNA splice site selection;7.0;0.8653626801206646;0.7836007053175329;9.533214072687796;66.59596265062147;6.343086423195323;0.002228906937441061;0.6753050999230941;[SETX, SLU7]
GO:0007221;positive regulation of transcription of Notch receptor target;12.0;1.0;0.9481203125901445;9.628524252492122;1467.8987330058965;6.8867018697843045;0.04912924957061573;0.8003065664753022;[EP300]
GO:0098792;xenophagy;7.0;1.0;0.8509193652572005;9.628524252492122;41.777574812335935;8.390779266560578;0.001398257831592581;0.7800242071602487;[CALCOCO2]
GO:0021860;pyramidal neuron development;7.0;1.0;0.8509193652572005;9.628524252492122;36.71755479978741;7.8311634786251565;0.0012289035154949403;0.7514054297404357;[ATP7A]
GO:0006378;mRNA polyadenylation;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;472.4435102429282;6.250713103064308;0.015812259116276064;0.734902770639515;[AHCYL1, PCF11, CPSF2]
GO:0006379;mRNA cleavage;8.0;0.8259837884571596;0.7879918942285797;9.474373572664863;348.0101069703874;6.518977089658987;0.01164758509153653;0.7083807915285978;[PCF11, CPSF2]
GO:0071284;cellular response to lead ion;6.0;1.0;0.8231203125901445;9.628524252492122;77.8106912628645;8.390779266560578;0.002604253811492351;0.7522251544931926;[ATP7A]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[SP3, ATP7A]
GO:0051453;regulation of intracellular pH;10.0;0.7192862368539868;0.7748841302879137;9.242861771680136;143.07278219841277;5.407625775213448;0.004788517263036519;0.6917872454856517;[SLC9A6, TM9SF4]
GO:0070072;vacuolar proton-transporting V-type ATPase complex assembly;8.0;1.0;0.875;9.628524252492122;45.210214189519135;7.474488534686424;0.0015131451823720294;0.7572456912631272;[TM9SF4]
GO:0030219;megakaryocyte differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;22.675663695230284;7.8311634786251565;7.589340571069517E-4;0.6907270763441554;[SP3]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[EP300]
GO:0019430;removal of superoxide radicals;5.0;1.0;0.7902410118609202;9.628524252492122;35.16553377750127;7.212124270218933;0.00117695876860726;0.659069382437994;[ATP7A]
GO:0071044;histone mRNA catabolic process;10.0;0.9326813400603323;0.8815816818910864;9.60383163990175;834.8214523265239;7.292166977892469;0.027940722718839572;0.7881627702307852;[DCP2]
GO:0010506;regulation of autophagy;6.0;0.6260725219892441;0.6361565735847665;8.273978589686811;43.35793677134884;4.08334148887777;0.001451151124127319;0.5319425862261522;[BECN1, HERC1, CALCOCO2, EP300, EXOC1]
GO:0010501;RNA secondary structure unwinding;7.0;1.0;0.8509193652572005;9.628524252492122;115.0816327851482;5.948432231191374;0.0038516786825735262;0.6551224661907153;[DDX59, DDX42, DDX41]
GO:0010742;macrophage derived foam cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;7.8311634786251565;7.282666309192915E-4;0.6907270763441554;[EP300]
GO:0071169;establishment of protein localization to chromatin;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;126.96280394857794;7.697632086000634;0.004249330789053679;0.7686572628545723;[NIPBL]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[CLK1, STK38L]
GO:0032876;negative regulation of DNA endoreduplication;10.0;1.0;0.9152410118609203;9.628524252492122;1221.9246883190933;7.9853141584524145;0.04089671965721659;0.8236103492792612;[STAG2]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[CLK1]
GO:0032875;regulation of DNA endoreduplication;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;171.6907107923128;7.57984905034425;0.00574633357861074;0.7838744581139225;[STAG2, SENP2]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[PTP4A1, NIPBL, KARS, DOCK8, CIB1, ATP7A, CLASP1]
GO:0043967;histone H4 acetylation;12.0;0.8259837884571596;0.8611122068187244;9.464221201200845;659.4528027923784;5.825829909099042;0.022071291840469662;0.7460535250702665;[EP300]
GO:0043966;histone H3 acetylation;12.0;0.7671156992804218;0.8316781622303555;9.3498108500231;659.4528027923784;5.926926025970411;0.022071291840469662;0.7512235851885185;[DR1]
GO:0043969;histone H2B acetylation;12.0;0.8933024483968273;0.8947715367885583;9.55953138100517;659.4528027923784;9.777073627680469;0.022071291840469662;0.9481203125901445;[EP300]
GO:1905406;positive regulation of mitotic cohesin loading;11.0;0.8933024483968273;0.8790801765280758;9.584072489921288;1181.6634555683206;9.777073627680469;0.039549212429805275;0.9324289523296623;[NIPBL]
GO:0006584;catecholamine metabolic process;6.0;0.7436939687323844;0.6949672969563367;9.223059144383958;80.36068301591426;6.015873511986907;0.0026895997406233426;0.6307723637598831;[MTPN, ATP7A]
GO:0061038;uterus morphogenesis;4.0;1.0;0.75;9.628524252492122;33.85048388619649;7.9853141584524145;0.0011329452322133542;0.6583693374183408;[NIPBL]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[SETX, CLK1, SNRK, ZMYM2, PAN3, KARS, PTPRA, FASTKD5, STK38L, CLK4]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[TAF7, CIB1]
GO:0010717;regulation of epithelial to mesenchymal transition;5.0;0.7140352122741334;0.6472586179979869;8.999915593069748;54.42428208907013;5.395046993006588;0.001821531742847262;0.5661439659786197;[CLASP1]
GO:0032508;DNA duplex unwinding;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;23.726073882073138;5.734022359845919;7.940903407527885E-4;0.64415753539903;[SETX, CHD1]
GO:0051228;mitotic spindle disassembly;8.0;1.0;0.875;9.628524252492122;183.6029335900273;9.083926447120524;0.006145024955345747;0.839552420951524;[SPAST]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[PHF3, ZNF394, NAB1, ARID4A, CHD1, RLF, YY1, NIPBL, ZMYM2, SAP130, DPF2, EP300, LRRFIP1, ZNF564, IER2, ZNF189, TLE4, DR1, NFYC, INTS3, CNOT10, ZFX, FLI1, CNOT6, CNOT1, NFIC, SP3, INTS4, LCOR, TAF7, CNOT8]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[PPP1CB, PTP4A1, PTPRA]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[MTPN, ZNF394, NAB1, ARID4A, CIB1, DDX41, AATF, CHD1, RLF, YY1, NIPBL, ZMYM2, SAP130, TPR, DPF2, DVL3, EP300, LRRFIP1, FADS1, ZNF564, IER2, ZNF189, TLE4, DR1, UBE2I, NCOA6, NFYC, ZFP91, CNOT10, SENP2, ZFX, FLI1, TOX4, SETX, CNOT6, THAP6, KARS, CNOT1, GOLGB1, NFIC, SP3, LCOR, TAF7, CNOT8]
GO:0006352;DNA-templated transcription, initiation;8.0;0.8259837884571596;0.7879918942285797;9.446202695698167;475.54218973470665;4.449197458890889;0.015915969130235397;0.6025321649565211;[NCOA6, TAF7]
GO:0042761;very long-chain fatty acid biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;456.7578576193329;7.212124270218933;0.01528727443913519;0.7650689957573628;[ELOVL5]
GO:0006479;protein methylation;8.0;0.5860072649471136;0.6680036324735568;8.391761625343195;206.79845698774034;4.917261223318797;0.006921358248851439;0.6264689676365554;[ARID4A, RLF, PCMTD1]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[ZNF394, ARID4A, DDX41, AATF, CHD1, RLF, YY1, NIPBL, ZMYM2, SAP130, TPR, DPF2, EP300, LRRFIP1, ZNF564, IER2, ZNF189, TLE4, DR1, UBE2I, NCOA6, NFYC, ZFP91, SENP2, ZFX, FLI1, TOX4, SETX, THAP6, CNOT1, NFIC, SP3, LCOR, TAF7]
GO:0098884;postsynaptic neurotransmitter receptor internalization;9.0;1.0;0.896240625180289;9.628524252492122;106.27993511699428;8.390779266560578;0.00355709378263404;0.8253454670833372;[SYNJ1]
GO:0006349;regulation of gene expression by genetic imprinting;7.0;0.8933024483968273;0.7975705894556142;9.577230958104572;130.9317736178294;6.8867018697843045;0.004382168632042727;0.7031056191423581;[ARID4A]
GO:0051353;positive regulation of oxidoreductase activity;5.0;0.6873818243518346;0.6339319240368375;8.560683622490766;68.71016387165909;5.905872616772578;0.002299667349651622;0.5922676121338333;[ATP7A]
GO:0010606;positive regulation of cytoplasmic mRNA processing body assembly;8.0;1.0;0.875;9.628524252492122;306.3544197830862;8.16763571524637;0.01025340672906212;0.7926932703116032;[CNOT6, PAN3, CNOT1]
GO:0019896;axonal transport of mitochondrion;9.0;0.8933024483968273;0.8428918493787028;9.54514264355307;228.1748032564258;7.379178354882098;0.007636805321001702;0.7736121494158466;[SPAST]
GO:0016266;O-glycan processing;9.0;0.7866048967936545;0.7895430735771163;9.277126365654233;178.64096908048714;5.666199763507158;0.0059789524686895724;0.6860103445912811;[GALNT10]
GO:0018205;peptidyl-lysine modification;8.0;0.5452700253111464;0.6476350126555732;7.816145496061331;154.24579517762936;4.212553220357776;0.005162467952392046;0.5904301675928552;[SENP6, DR1, UBE2I, SUMO3, VPS33B, ARID4A, EP300, ATP7A, SENP2, RLF]
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[YY1, SETX, NIPBL, WDR48, NCOA6, INTS3, EP300, CIB1]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[RNF38]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[EP300]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[MTPN, UBE2I, EP300, CIB1]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[MTPN, CIB1]
GO:0046855;inositol phosphate dephosphorylation;8.0;0.9326813400603323;0.8413406700301662;9.590783924509275;336.6569207659842;7.138016298065211;0.011267604166479381;0.7400384854347593;[SYNJ1]
GO:0046856;phosphatidylinositol dephosphorylation;8.0;1.0;0.875;9.628524252492122;218.1540246804484;6.686031174322154;0.007301418880178951;0.7169239451870815;[SYNJ1]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[TLE4, DR1, UBE2I, NAB1, NFYC, ARID4A, YY1, NIPBL, CNOT1, NFIC, SAP130, TPR, SP3, DPF2, EP300, LCOR, TAF7, LRRFIP1, ZNF564, ZNF189]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[RIC8A, ALS2, EIF4E2, ATP7A, SEC24C]
GO:0019367;fatty acid elongation, saturated fatty acid;10.0;1.0;0.9152410118609203;9.628524252492122;363.0266052285773;7.8311634786251565;0.012150173774267114;0.8157270763441555;[ELOVL5]
GO:0034626;fatty acid elongation, polyunsaturated fatty acid;11.0;1.0;0.9324289523296623;9.628524252492122;363.71975240913724;7.8311634786251565;0.012173372786608494;0.8329150168128974;[ELOVL5]
GO:0031116;positive regulation of microtubule polymerization;10.0;0.8933024483968273;0.861892236059334;9.589303539338841;431.61701704611926;6.518977089658987;0.014445833130437288;0.7486218033895181;[CLASP1]
GO:0001829;trophectodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;7.212124270218933;7.050676185779127E-4;0.6188283705770736;[SP3]
GO:0034625;fatty acid elongation, monounsaturated fatty acid;11.0;1.0;0.9324289523296623;9.628524252492122;363.71975240913724;7.8311634786251565;0.012173372786608494;0.8329150168128974;[ELOVL5]
GO:0032688;negative regulation of interferon-beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.82850979692678;7.138016298065211;0.00283913388220078;0.7159578506919597;[YY1]
GO:0030148;sphingolipid biosynthetic process;7.0;0.6913464685778243;0.6965925995461126;8.992535485772125;238.8284648682076;5.288437257948329;0.007993373787475071;0.6213702925661609;[ELOVL5]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[RAB21, ALS2, DOCK8, RAB18, DOCK2, KPNB1]
GO:0007020;microtubule nucleation;6.0;0.7980440201809971;0.722142322680643;9.0689084645567;33.1981629444775;6.686031174322154;0.0011111126373447525;0.665044257777226;[NIN, TUBGCP2, CLASP1]
GO:0090222;centrosome-templated microtubule nucleation;8.0;1.0;0.875;9.628524252492122;35.68306959426445;9.083926447120524;0.001194280226642328;0.839552420951524;[NIN]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[ALS2, SPG11, PAFAH1B1]
GO:0007026;negative regulation of microtubule depolymerization;10.0;0.8933024483968273;0.861892236059334;9.54514264355307;364.4217241224184;6.599019797332524;0.012196867148118488;0.7527151911823093;[CIB1, CLASP1]
GO:0043353;enucleate erythrocyte differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;24.061958056348765;8.16763571524637;8.053320817896622E-4;0.7408135829017477;[SP3]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[EP300, CIB1]
GO:0042149;cellular response to glucose starvation;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;115.90251486529202;6.063501560976162;0.003879152867050031;0.6610071170671804;[BECN1]
GO:0045898;regulation of RNA polymerase II transcriptional preinitiation complex assembly;12.0;0.8933024483968273;0.8947715367885583;9.551563211355994;535.2186768680203;7.069023426578259;0.017913287449235833;0.8096304993685645;[DR1]
GO:0045778;positive regulation of ossification;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.729731686539594;5.370354380416217;0.0013966565652281952;0.5648811846224242;[NIPBL]
GO:2000806;positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled;13.0;1.0;0.9625549647676366;9.628524252492122;4059.4929617747066;9.777073627680469;0.13586757612412656;0.9625549647676366;[SETX]
GO:0016082;synaptic vesicle priming;6.0;1.0;0.8231203125901445;9.628524252492122;54.68230325191999;7.474488534686424;0.001830167478963876;0.7053660038532718;[SYNJ1, SNAP29]
GO:0045540;regulation of cholesterol biosynthetic process;9.0;0.8933024483968273;0.8428918493787028;9.4949928598676;116.98845768213258;6.039404009397101;0.0039154983958446;0.705096027081865;[NFYC, KPNB1]
GO:1990414;replication-born double-strand break repair via sister chromatid exchange;10.0;1.0;0.9152410118609203;9.628524252492122;521.7226431472901;8.390779266560578;0.01746158734624478;0.8443458537639685;[NIPBL]
GO:0043484;regulation of RNA splicing;7.0;0.7671156992804218;0.7344772148974115;9.34084218004034;89.9604162809808;4.901876304479318;0.0030108941738060855;0.601601547428833;[SETX, CLK1, CLK4]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[UPF2]
GO:0071921;cohesin loading;8.0;0.8653626801206646;0.8076813400603323;9.517298617381897;71.05163662975816;9.083926447120524;0.002378034335676526;0.839552420951524;[NIPBL]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[NCOA6, NFIC]
GO:0048812;neuron projection morphogenesis;7.0;0.6547035408479693;0.6782711356811852;8.502512989635898;62.99970935475633;4.360973225476049;0.002108543576046295;0.5739397388140403;[SLC9A6, ALS2, ATP7A, PAFAH1B1]
GO:0007595;lactation;6.0;1.0;0.8231203125901445;9.628524252492122;25.956233089099676;5.9928839937622085;8.687317623989867E-4;0.6295966787287501;[ATP7A]
GO:0043488;regulation of mRNA stability;9.0;0.7436939687323844;0.7680876095464813;9.240758721483358;282.23354693635815;4.989581884898423;0.009446102822258332;0.6514080748132811;[DCP2]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[WIPF2]
GO:0043491;protein kinase B signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.250713103064308;8.845336528452411E-4;0.6427820713687392;[SETX]
GO:0016191;synaptic vesicle uncoating;9.0;1.0;0.896240625180289;9.628524252492122;42.883923758655996;8.16763571524637;0.0014352863351765049;0.8139338954918922;[SYNJ1]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[TPR, SLU7]
GO:0045793;positive regulation of cell size;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;29.63014819255531;7.379178354882098;9.916943946027175E-4;0.7004918368257019;[ATP7A]
GO:2000812;regulation of barbed-end actin filament capping;11.0;0.8933024483968273;0.8790801765280758;9.5544162803384;296.5111712891794;8.390779266560578;0.009923962060319572;0.8615337942327104;[MTPN]
GO:0060707;trophoblast giant cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;42.294635617598914;7.292166977892469;0.0014155633914202197;0.6631627702307852;[SENP2]
GO:0070863;positive regulation of protein exit from endoplasmic reticulum;9.0;0.9326813400603323;0.8625812952104552;9.582004236857228;386.41577867641314;7.212124270218933;0.012932988360676686;0.7650689957573628;[TMEM30A, TM9SF4]
GO:0010634;positive regulation of epithelial cell migration;8.0;0.7866048967936545;0.7683024483968273;9.383401794459138;242.52723865374625;4.901876304479318;0.00811716841739676;0.6256821821716325;[CIB1, CLASP1]
GO:0010890;positive regulation of sequestering of triglyceride;7.0;1.0;0.8509193652572005;9.628524252492122;69.4460343959197;7.8311634786251565;0.002324296273858149;0.7514054297404357;[OSBPL11]
GO:0000724;double-strand break repair via homologous recombination;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;520.6240308586224;5.299736813202263;0.01742481778162994;0.6672694122704188;[YY1, NIPBL, WDR48]
GO:0044344;cellular response to fibroblast growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.444869117505266;0.003262744749111514;0.6527112189764278;[SETX]
GO:0048821;erythrocyte development;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;33.53950096943652;6.832634648514029;0.0011225369138558525;0.639662265535933;[ARID4A]
GO:0006396;RNA processing;7.0;0.49247393176386933;0.5971563311391352;7.484544189674715;115.0816327851482;3.0330144413691222;0.0038516786825735262;0.5060278648384131;[AHCYL1, INTS3, CPSF2, DDX42, DDX41, SRRM1, EFTUD2, SETX, PAN3, KARS, PCF11, FASTKD5, INTS4, SLU7, SMNDC1]
GO:0006397;mRNA processing;8.0;0.7140352122741334;0.7320176061370667;9.165900730544008;234.3529203123214;3.6745150330669007;0.00784358133891816;0.5629148696734654;[EFTUD2, AHCYL1, PAN3, PCF11, CPSF2, DDX42, FASTKD5, DDX41, SLU7, SMNDC1, SRRM1]
GO:1902902;negative regulation of autophagosome assembly;9.0;1.0;0.896240625180289;9.628524252492122;476.81513928252696;7.292166977892469;0.015958573606020727;0.769162383550154;[BECN1]
GO:0016180;snRNA processing;9.0;0.7980440201809971;0.7952626352707877;9.354087406790361;356.38664419027253;6.221725566191056;0.01192794025389202;0.7144199599751273;[INTS3, INTS4]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[KARS, ALS2, DVL3, ZFP91, CIB1, SENP2]
GO:0030111;regulation of Wnt signaling pathway;6.0;0.5902001590945054;0.6182203921373972;7.99439372746765;41.8512380110395;4.069963362931594;0.0014007232725606145;0.5312584282431182;[TLE4, DVL3, SENP2]
GO:0017157;regulation of exocytosis;7.0;0.5887823193610073;0.6453105249377042;8.01908634005802;60.10293961547554;4.60092389510664;0.0020115912997960765;0.5862108272177959;[RAB21, PDCD6IP, CLASP1]
GO:0010762;regulation of fibroblast migration;7.0;0.8259837884571596;0.7639112594857803;9.427853557029971;40.03709713961528;6.481236761676141;0.0013400056102148314;0.6823701146576509;[RFFL]
GO:0051294;establishment of spindle orientation;7.0;0.8653626801206646;0.7836007053175329;9.517298617381897;88.53546790794914;6.343086423195323;0.002963202434130993;0.6753050999230941;[CLASP1, PAFAH1B1]
GO:0051170;import into nucleus;7.0;0.7436939687323844;0.7227663496233927;8.935377071932177;33.8974465615721;5.076593261888053;0.001134517030694512;0.6105365807558851;[TPR, RAB18, NUP153, TNPO2, KPNB1]
GO:0051292;nuclear pore complex assembly;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;123.37008173774021;7.474488534686424;0.004129085609897011;0.7053660038532718;[NUP153]
GO:0009597;detection of virus;6.0;1.0;0.8231203125901445;9.628524252492122;28.654098265158677;8.16763571524637;9.59026881920657E-4;0.7408135829017477;[SERINC3]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[RIC8A, RABGAP1, ALS2, DOCK8, DVL3, DOCK2]
GO:0045723;positive regulation of fatty acid biosynthetic process;8.0;0.7980440201809971;0.7740220100904985;9.446202695698167;668.0274522036976;7.004484905440688;0.022358277639583056;0.7332096838060964;[ELOVL5]
GO:0018076;N-terminal peptidyl-lysine acetylation;10.0;0.9326813400603323;0.8815816818910864;9.585964638073326;676.4251839632358;8.67846133901236;0.022639342164106888;0.8590579283277371;[EP300]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[SENP2]
GO:0031397;negative regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;529.4632463014641;5.572381008289503;0.01772065836772442;0.7002128357670632;[GNL3L, SENP2]
GO:0010458;exit from mitosis;5.0;1.0;0.7902410118609202;9.628524252492122;29.819065850336454;7.379178354882098;9.980172985937987E-4;0.6676125360964777;[SPAST, CLASP1]
GO:0032006;regulation of TOR signaling;7.0;0.7866048967936545;0.7442218136540277;9.260799472366804;45.070113835906206;5.244474134527214;0.001508456149618737;0.6191220163899107;[RFFL]
GO:0010592;positive regulation of lamellipodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;310.04759849733875;6.8867018697843045;0.010377014096983099;0.7484268790654467;[ATP7A]
GO:0010470;regulation of gastrulation;6.0;0.5860072649471136;0.6161239450637013;7.99439372746765;45.909253739235254;6.139487467954083;0.0015365414070062774;0.6370939872166814;[CLASP1]
GO:0007062;sister chromatid cohesion;5.0;0.7508913569872202;0.6656866903545304;8.801845679307654;32.565640385727406;6.113511981550823;0.001089942676536732;0.6028862989048107;[NIPBL, STAG2]
GO:0035871;protein K11-linked deubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;204.99431233642397;7.474488534686424;0.006860975150996652;0.7974867031240476;[VCPIP1]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[SP3, EP300]
GO:0030182;neuron differentiation;4.0;0.5833093054345528;0.5416546527172764;7.212610474191073;21.066225782797595;4.296434704338478;7.050676185779127E-4;0.4697198705845162;[MTPN, HERC1, ATP7A, IER2, PAFAH1B1]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[EP300, DDX41, LRRFIP1]
GO:0007064;mitotic sister chromatid cohesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;49.163113097731234;7.212124270218933;0.0016454451514518356;0.6919486831672181;[NIPBL]
GO:0032482;Rab protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;5.500407508664414;9.9090025448413E-4;0.6562910957882058;[RAB21, RAB18]
GO:0000305;response to oxygen radical;5.0;0.8653626801206646;0.7229223519212526;9.510741216835738;40.057724129811376;7.474488534686424;0.001340695977013609;0.6724867031240476;[TXNRD1]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[TMEM30A, PSMB1, RAB18, DOCK2, SNAP29, KPNB1]
GO:0000423;mitophagy;7.0;1.0;0.8509193652572005;9.628524252492122;142.40942525886626;7.9853141584524145;0.004766315303252383;0.7592887026755414;[BECN1]
GO:0001756;somitogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;43.80328827915336;5.845247994956144;0.0014660566383032007;0.5891672661548076;[EP300]
GO:0042471;ear morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;47.43365404998557;8.390779266560578;0.0015875617135358803;0.7193458537639684;[NIPBL]
GO:0031146;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;350.55619955642163;6.063501560976162;0.011732800519056534;0.7253287636709003;[FBXL3]
GO:0034773;histone H4-K20 trimethylation;12.0;1.0;0.9481203125901445;9.628524252492122;1138.7372665109895;7.9853141584524145;0.03811251151311841;0.8564896500084854;[ARID4A]
GO:0031023;microtubule organizing center organization;3.0;0.7307253602413294;0.5634829927108093;8.465373442686442;24.42168715513283;5.459585514144159;8.173718909907947E-4;0.47732376968016754;[CLASP1, PAFAH1B1]
GO:1904261;positive regulation of basement membrane assembly involved in embryonic body morphogenesis;8.0;1.0;0.875;9.628524252492122;259.3501328849454;8.16763571524637;0.008680215547693135;0.7926932703116032;[CLASP1]
GO:0090307;mitotic spindle assembly;8.0;1.0;0.875;9.628524252492122;186.05212215721153;6.193554689224359;0.006226997092562797;0.6917386748366816;[TUBGCP2, KPNB1, CLASP1]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[WIPF2]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[VPS18, NUP153]
GO:0008361;regulation of cell size;5.0;0.7763722522362496;0.6784271379790451;8.999915593069748;28.02071028012121;5.54296712308321;9.378279560736312E-4;0.5737086083097278;[MTPN, ATP7A]
GO:0046832;negative regulation of RNA export from nucleus;8.0;0.8436909121759173;0.7968454560879586;9.446202695698167;195.26423809717332;9.083926447120524;0.006535318322707228;0.839552420951524;[TPR, NUP153]
GO:0045747;positive regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;187.6437959822434;5.926926025970411;0.006280268983073171;0.6540226378555745;[EP300]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[PSMB1, FBXL3]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[YY1, EP300]
GO:0035855;megakaryocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;66.38585475831493;7.069023426578259;0.0022218748153703875;0.6517511986393402;[EP300, FLI1]
GO:0032465;regulation of cytokinesis;6.0;0.5930994877375815;0.6196700564589352;8.140447197062288;31.798591743249187;5.358233019883872;0.0010642702487719462;0.5971405984103235;[BECN1, SPAST]
GO:0010557;positive regulation of macromolecule biosynthetic process;6.0;0.4534437668551258;0.5498421960177073;6.623742143418212;113.59174636189375;2.32757562229762;0.003801813524797928;0.44215263815778055;[MTPN, DR1, NCOA6, NFYC, ARID4A, DDX41, AATF, SENP2, RLF, FLI1, YY1, SETX, NIPBL, KARS, NFIC, SP3, DPF2, DVL3, EP300, TAF7, ZNF564, IER2]
GO:0032467;positive regulation of cytokinesis;7.0;0.7043150770688792;0.7030769037916401;9.015419779605713;142.0565341908292;6.193554689224359;0.004754504356786525;0.6676580400938822;[SPAST]
GO:0070936;protein K48-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;5.8650506222523235;0.00527474598481953;0.7323679139043926;[RFFL]
GO:0034760;negative regulation of iron ion transmembrane transport;9.0;0.8653626801206646;0.8289219652406215;9.481920778300246;303.36553502499083;9.083926447120524;0.010153371446030313;0.8607930461318132;[ATP7A]
GO:0032460;negative regulation of protein oligomerization;7.0;0.8653626801206646;0.7836007053175329;9.548481544818586;114.68680095945324;6.943860283624253;0.003838464016693089;0.7060287030842711;[EP300]
GO:0045995;regulation of embryonic development;5.0;0.5017827139744404;0.5411323688481404;6.887684228566921;27.37613670804801;4.981283082083729;9.162546586948941E-4;0.5449840603320351;[NIPBL, DVL3, CLASP1, PAFAH1B1]
GO:0031124;mRNA 3'-end processing;9.0;0.8436909121759173;0.8180860812682478;9.52844079393514;355.1646528804444;5.407625775213448;0.011887041304472852;0.6727868588050205;[AHCYL1, PCF11, CPSF2, SLU7, SRRM1]
GO:0032211;negative regulation of telomere maintenance via telomerase;10.0;1.0;0.9152410118609203;9.628524252492122;1705.737369485817;6.781341354126479;0.05708949469272255;0.7620391240755716;[GNL3L, DCP2]
GO:0031122;cytoplasmic microtubule organization;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;50.45034613020222;5.734022359845919;0.0016885276826141221;0.6163584827319739;[SPAST, TUBGCP2, CIB1, KPNB1, CLASP1, PAFAH1B1]
GO:0035562;negative regulation of chromatin binding;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;31.329781184124332;7.57984905034425;0.0010485795812601483;0.6778748447945537;[SENP2]
GO:0007093;mitotic cell cycle checkpoint;7.0;0.7140352122741334;0.7079369713942671;9.0094850440859;132.2042645947957;5.142344639450834;0.0044247577598742595;0.6138991092621975;[INTS3, TPR]
GO:0016925;protein sumoylation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;311.84626772129184;6.250713103064308;0.010437213937211602;0.7159023839588838;[SENP6, UBE2I, SUMO3, SENP2]
GO:0016926;protein desumoylation;9.0;1.0;0.896240625180289;9.628524252492122;360.64887473102675;7.697632086000634;0.012070593274332617;0.7898978880348613;[SENP6, SENP2]
GO:0007097;nuclear migration;5.0;0.7140352122741334;0.6472586179979869;8.712233520617966;66.0178211805495;6.781341354126479;0.002209557062731295;0.6370391240755715;[DCTN4, PAFAH1B1]
GO:0060765;regulation of androgen receptor signaling pathway;7.0;0.8436909121759173;0.7727648213451592;9.427853557029971;43.64299748026755;6.518977089658987;0.0014606918495168463;0.6843001567857983;[EP300]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[BECN1, EP300, ITPR2, ATP7A, TM9SF4]
GO:0015949;nucleobase-containing small molecule interconversion;6.0;0.7671156992804218;0.7066781622303554;9.271849308553389;109.52544358977337;6.409777797693995;0.003665718030449963;0.6509166472493662;[TXNRD1]
GO:0071774;response to fibroblast growth factor;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;24.053434438352202;6.221725566191056;8.050468039660755E-4;0.6084203466557585;[SETX, IER2]
GO:0015825;L-serine transport;11.0;0.8933024483968273;0.8790801765280758;9.510741216835738;156.85333935075835;7.474488534686424;0.005249740109229274;0.8146746435927894;[SERINC3]
GO:0050714;positive regulation of protein secretion;8.0;0.6467165523344657;0.6983582761672329;8.730582659286164;381.48337166918856;4.304802954008995;0.01276790513702299;0.5951478232618299;[KARS, EXOC1]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[DOCK8, ITPR2, CNOT10, KRCC1, RAB21, SETX, CNOT6, SNRK, GNG2, KARS, ALS2, PTPRA, CNOT1, RAB18, DVL3, CASP2, EP300, STK38L, DOCK2, CNOT8, KPNB1, EXOC1]
GO:2000406;positive regulation of T cell migration;10.0;0.7980440201809971;0.8142630219514189;9.461470167828956;351.7821234142529;6.518977089658987;0.011773831087318304;0.7486218033895181;[DOCK8]
GO:0070550;rDNA condensation;7.0;1.0;0.8509193652572005;9.628524252492122;23.949217433387346;9.777073627680469;8.01558754599117E-4;0.8509193652572005;[NIPBL]
GO:0045022;early endosome to late endosome transport;6.0;1.0;0.8231203125901445;9.628524252492122;50.18376484494501;6.686031174322154;0.001679605446904144;0.665044257777226;[BECN1]
GO:0030099;myeloid cell differentiation;4.0;0.6913464685778243;0.5956732342889122;8.146919711567906;21.066225782797595;4.720827822332161;7.050676185779127E-4;0.49142335437501145;[SNRK, NCOA6, SP3, EP300, CIB1]
GO:0031069;hair follicle morphogenesis;4.0;1.0;0.75;9.628524252492122;21.56700107071243;6.518977089658987;7.21828116795923E-4;0.5833807915285978;[ATP7A]
GO:2000643;positive regulation of early endosome to late endosome transport;8.0;1.0;0.875;9.628524252492122;187.5816030452836;7.697632086000634;0.006278187441443136;0.7686572628545723;[RAB21]
GO:0034214;protein hexamerization;6.0;1.0;0.8231203125901445;9.628524252492122;42.032160359171186;7.474488534686424;0.00140677858073304;0.7053660038532718;[SPAST]
GO:0034696;response to prostaglandin F;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;73.02034848846884;9.083926447120524;0.00244392534986193;0.8154717862087246;[YY1]
GO:0034454;microtubule anchoring at centrosome;8.0;1.0;0.875;9.628524252492122;34.58445730559739;7.57984905034425;0.0011575106620275101;0.7626338329336335;[NIN]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[CLASP1, PAFAH1B1]
GO:0007191;adenylate cyclase-activating dopamine receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;86.3328748592354;7.474488534686424;0.0028894836269955926;0.7974867031240476;[GNG2]
GO:0007076;mitotic chromosome condensation;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;40.5466901453896;7.004484905440688;0.0013570612295141678;0.7332096838060964;[NIPBL]
GO:0034453;microtubule anchoring;6.0;0.811012628672052;0.7286266269261705;9.223059144383958;33.1981629444775;6.558197802812269;0.0011111126373447525;0.6585068532133508;[NIN, CLASP1]
GO:0031065;positive regulation of histone deacetylation;10.0;0.8933024483968273;0.861892236059334;9.571365838652174;1219.9035963218012;6.8867018697843045;0.04082907552693193;0.7674272657460779;[NIPBL]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[BECN1, KARS, CIB1, CNOT8]
GO:0033120;positive regulation of RNA splicing;8.0;0.8933024483968273;0.8216512241984136;9.584072489921288;456.71654511042715;6.221725566191056;0.015285891746640958;0.6931793347948383;[SETX]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[CNOT6, WDR48, CIB1, ATP7A, CNOT8]
GO:0007079;mitotic chromosome movement towards spindle pole;7.0;1.0;0.8509193652572005;9.628524252492122;93.22236288778774;8.67846133901236;0.0031200685911745604;0.7947362817240173;[KPNB1]
GO:0001892;embryonic placenta development;5.0;1.0;0.7902410118609202;9.628524252492122;37.179255381886215;6.832634648514029;0.0012443562184742403;0.639662265535933;[SP3]
GO:0031291;Ran protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;8.67846133901236;9.9090025448413E-4;0.8188169164668168;[KPNB1]
GO:0090168;Golgi reassembly;5.0;1.0;0.7902410118609202;9.628524252492122;38.9171646647865;8.390779266560578;0.0013025224781561028;0.7193458537639684;[VCPIP1]
GO:0090169;regulation of spindle assembly;9.0;0.8653626801206646;0.8289219652406215;9.434368238051164;88.01535079215638;6.518977089658987;0.0029457945823404236;0.7296214167088868;[SENP6, STAG2, TPR]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[ZFP91, FBXL3, RFFL, C18orf25]
GO:0090043;regulation of tubulin deacetylation;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;77.05108112115013;7.57984905034425;0.0025788303436539155;0.7838744581139225;[EP300]
GO:0048666;neuron development;4.0;0.6696747006330769;0.5848373503165385;8.088079211544972;32.15320660831846;4.814228997420562;0.001076138889173156;0.4961998948126311;[BECN1, ATP7A, PAFAH1B1]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TLE4]
GO:0019054;modulation by virus of host process;7.0;0.5470854108181258;0.6244620706662634;7.695686185004162;74.19637833408251;6.641579411751319;0.0024832860104364728;0.6905700452391912;[KPNB1]
GO:0048675;axon extension;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;51.99108915072818;6.221725566191056;0.0017400949649324319;0.6084203466557585;[SLC9A6, SPG11]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[SETX]
GO:0001779;natural killer cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;64.35544597283358;7.474488534686424;0.0021539188605695985;0.7053660038532718;[SP3]
GO:2000786;positive regulation of autophagosome assembly;9.0;1.0;0.896240625180289;9.628524252492122;594.8628679994155;7.379178354882098;0.019909524850116572;0.7736121494158466;[BECN1]
GO:0030199;collagen fibril organization;5.0;1.0;0.7902410118609202;9.628524252492122;53.964823970696955;5.9928839937622085;0.0018061540931107725;0.5967173779995258;[ATP7A]
GO:0007080;mitotic metaphase plate congression;7.0;1.0;0.8509193652572005;9.628524252492122;61.63195576956532;6.193554689224359;0.002062766094448262;0.6676580400938822;[BECN1, KPNB1]
GO:0032258;protein localization by the Cvt pathway;7.0;1.0;0.8509193652572005;9.628524252492122;42.468841419009195;8.67846133901236;0.001421393902818379;0.7947362817240173;[BECN1]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[GNL3L, EP300]
GO:0045324;late endosome to vacuole transport;5.0;0.8653626801206646;0.7229223519212526;9.427853557029971;60.37325806554828;6.943860283624253;0.0020206386150492003;0.6453503496879909;[BECN1]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[CLK1, CLK4]
GO:0045444;fat cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[NIPBL, EP300, OSBPL11, SENP2]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[GNL3L, SENP2]
GO:0000380;alternative mRNA splicing, via spliceosome;12.0;0.9326813400603323;0.9144609826203107;9.584072489921288;357.76734256588776;7.004484905440688;0.011974150985975996;0.8063299963962409;[SLU7]
GO:0043153;entrainment of circadian clock by photoperiod;6.0;1.0;0.8231203125901445;9.628524252492122;32.762264927729;6.686031174322154;0.001096523523006926;0.665044257777226;[PPP1CB, FBXL3]
GO:0071733;transcriptional activation by promoter-enhancer looping;12.0;1.0;0.9481203125901445;9.628524252492122;1507.3475948689336;8.390779266560578;0.05044956747550087;0.8772251544931927;[NIPBL]
GO:0035115;embryonic forelimb morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;58.806290969860136;6.343086423195323;0.001968193636535348;0.647506047256038;[NIPBL]
GO:0090389;phagosome-lysosome fusion involved in apoptotic cell clearance;8.0;1.0;0.875;9.628524252492122;65.8060249050737;9.777073627680469;0.0022024684319953925;0.875;[SPG11]
GO:0060712;spongiotrophoblast layer development;4.0;1.0;0.75;9.628524252492122;49.67194865438347;7.697632086000634;0.0016624754196107158;0.6436572628545723;[SENP2]
GO:0045454;cell redox homeostasis;5.0;1.0;0.7902410118609202;9.628524252492122;31.944097044200298;5.572381008289503;0.0010691401802485107;0.5752128357670632;[TXNRD1]
GO:0000147;actin cortical patch assembly;7.0;1.0;0.8509193652572005;9.628524252492122;89.93282460404566;7.9853141584524145;0.0030099707052099636;0.7592887026755414;[WIPF2]
GO:0000389;mRNA 3'-splice site recognition;8.0;0.9326813400603323;0.8413406700301662;9.541512875502493;67.28910983118142;7.9853141584524145;0.0022521059497824397;0.7833693374183408;[SLU7]
GO:0061921;peptidyl-lysine propionylation;8.0;1.0;0.875;9.628524252492122;153.63965937405905;9.777073627680469;0.005142181132533355;0.875;[EP300]
GO:0060711;labyrinthine layer development;4.0;1.0;0.75;9.628524252492122;34.608406302298;7.697632086000634;0.001158312213394382;0.6436572628545723;[SENP2]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[KBTBD4, UBE2I, KCTD10, PSMB1, RNF38, FBXL3, RFFL, C18orf25]
GO:0090234;regulation of kinetochore assembly;8.0;0.8259837884571596;0.7879918942285797;9.461470167828956;86.89846841123497;8.67846133901236;0.0029084135341798686;0.8188169164668168;[SENP6]
GO:0008089;anterograde axonal transport;9.0;0.8259837884571596;0.8092325194088689;9.405380701177911;71.1020239957658;6.113511981550823;0.0023797207554711163;0.7088859122241795;[RAB21, SPAST]
GO:0008088;axo-dendritic transport;7.0;0.6799073451904818;0.6908730378524415;8.935377071932177;68.32943527352603;5.769740442447999;0.002286924706105601;0.6459841598043611;[RAB21, SPAST, SPG11, PAFAH1B1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[TLE4, DR1, UBE2I, YY1, NIPBL, CNOT1, NFIC, SAP130, TPR, SP3, EP300, LCOR, TAF7, LRRFIP1, ZNF564, ZNF189]
GO:0071870;cellular response to catecholamine stimulus;7.0;0.8436909121759173;0.7727648213451592;9.454170865347344;343.956301250774;6.221725566191056;0.011511907862289356;0.6690987000520388;[GNG2]
GO:0035338;long-chain fatty-acyl-CoA biosynthetic process;8.0;1.0;0.875;9.628524252492122;500.3176215265477;6.8867018697843045;0.016745180535867314;0.7271862538851576;[ELOVL5]
GO:1990869;cellular response to chemokine;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;7.9853141584524145;0.0027327542132076126;0.7314896500084853;[DOCK8]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[SETX, BECN1]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTP4A1, PTPRA]
GO:0042093;T-helper cell differentiation;10.0;0.8436909121759173;0.837086467948879;9.485423408851448;472.3173309007748;6.943860283624253;0.015808036007248224;0.7703503496879909;[ATP7A]
GO:0044030;regulation of DNA methylation;7.0;0.7980440201809971;0.7499413753476991;9.253830803050711;73.34977914704017;6.7325511899570465;0.0024549510975359675;0.6952223462072524;[RLF]
GO:1903905;positive regulation of establishment of T cell polarity;9.0;1.0;0.896240625180289;9.628524252492122;265.46342291935315;9.083926447120524;0.008884821863540926;0.8607930461318132;[DOCK8]
GO:0001578;microtubule bundle formation;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;33.1981629444775;5.8067817141283475;0.0011111126373447525;0.6200793994936333;[SPAST, CLASP1]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SETX, BECN1, DOCK8, CASP2, CIB1, AATF, RFFL]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[TM9SF4]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[SETX, BECN1, TXNRD1]
